![](/img/cover-not-exists.png)
Phase III, single-arm study investigating the efficacy, safety, and tolerability of anagrelide as a second-line treatment in high-risk Japanese patients with essential thrombocythemia
Kanakura, Yuzuru, Miyakawa, Yoshitaka, Wilde, Paul, Smith, Jonathan, Achenbach, Heinrich, Okamoto, ShinichiroVolume:
100
Language:
english
Journal:
International Journal of Hematology
DOI:
10.1007/s12185-014-1631-x
Date:
October, 2014
File:
PDF, 373 KB
english, 2014